Cargando…
PFKFB3-Mediated Glycolysis Boosts Fibroblast Activation and Subsequent Kidney Fibrosis
Renal fibrosis, a hallmark of chronic kidney diseases, is driven by the activation of renal fibroblasts. Recent studies have highlighted the role of glycolysis in this process. Nevertheless, one critical glycolytic activator, 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3), remains u...
Autores principales: | Yang, Qiuhua, Huo, Emily, Cai, Yongfeng, Zhang, Zhidan, Dong, Charles, Asara, John M., Wei, Qingqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453197/ https://www.ncbi.nlm.nih.gov/pubmed/37626891 http://dx.doi.org/10.3390/cells12162081 |
Ejemplares similares
-
Myeloid PFKFB3-mediated glycolysis promotes kidney fibrosis
por: Yang, Qiuhua, et al.
Publicado: (2023) -
Suppression of myeloid PFKFB3‐driven glycolysis protects mice from choroidal neovascularization
por: Liu, Zhiping, et al.
Publicado: (2022) -
Anlotinib Inhibits PFKFB3-Driven Glycolysis in Myofibroblasts to Reverse Pulmonary Fibrosis
por: Chen, Weimou, et al.
Publicado: (2021) -
IGFBP5 promotes diabetic kidney disease progression by enhancing PFKFB3-mediated endothelial glycolysis
por: Song, Chengcheng, et al.
Publicado: (2022) -
Role of PFKFB3-driven glycolysis in sepsis
por: Xiao, Min, et al.
Publicado: (2023)